AngioLab (XKRX:251280) Cash Flow for Lease Financing : ₩-60.6 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab Cash Flow for Lease Financing?

AngioLab's Cash Flow for Lease Financing for the six months ended in Dec. 2023 was ₩-60.6 Mil. AngioLab's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-60.6 Mil.

Compared with last quarter (₩-62.8 Mil in Dec. 2022 ), AngioLab's Cash Flow for Lease Financing increased in Dec. 2023 (₩-60.6 Mil).

AngioLab Cash Flow for Lease Financing Historical Data

The historical data trend for AngioLab's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Cash Flow for Lease Financing Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Lease Financing

Get a 7-Day Free Trial

-42.00

-50.25

-50.33

-62.76

-60.63

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Cash Flow for Lease Financing	Get a 7-Day Free Trial			-42.00	-50.25	-50.33	-62.76	-60.63

AngioLab Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-60.6 Mil.

AngioLab Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of AngioLab's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines